NOTES

Discovery of a New Polycyclic Tetramate Macrolactam 3-Hydroxycombamide I

  • Yaqian Yan ,
  • Haoxin Wang ,
  • Yaoyao Li
Expand
  • a Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan 250012
    b State Key Laboratory of Microbial Technology, Shandong University, Qingdao, Shandong 266237
*Corresponding author. E-mail:

Received date: 2021-10-02

  Revised date: 2022-01-14

  Online published: 2022-01-21

Supported by

National Natural Science Foundation of China(81773598); Young Scholars Program of Shandong University(2016WLJH31); Program for Changjiang Scholars and Innovative Research Team in University(IRT_17R68)

Abstract

3-Hydroxycombamide I (2), a new polycyclic tetramate macrolactam (PoTeM) bearing a 5/5/6 cyclization pattern was isolated from the recombinant strain S001-cbm-OX4-ikaD, which is derived from Streptomyces sp. S001 by integration of the modified combamides biosynthetic gene cluster. The chemical structure of 2 was determined by analysis of 1D and 2D-NMR and HRMS data. The hydroxylation of compound 2 at C-3 was deduced to be catalyzed by a hydroxylase of Streptomyces sp. S001. The antibacterial and cytotoxic activity of compound 2 was evaluated by filter paper disc diffusion and methyl thiazolyl tetrazolium (MTT) assay, respectively. The effect of compound 2 on inhibition of the T3SS (type III secretion system) of Salmonella enterica serovar Typhimurium was also investigated. However, compound 2 was inactivity in all assays. The results indicated that the hydroxylation at C-3 may occurs after the oxidative modifictions of the polycyclic system in the biosynthesis of PoTeMs.

Cite this article

Yaqian Yan , Haoxin Wang , Yaoyao Li . Discovery of a New Polycyclic Tetramate Macrolactam 3-Hydroxycombamide I[J]. Chinese Journal of Organic Chemistry, 2022 , 42(5) : 1557 -1561 . DOI: 10.6023/cjoc202110001

References

[1]
Cao, S.; Blodgett, J.; Clardy, J. Org. Lett. 2010, 12, 4652.
[2]
Zhang, G.; Zhang, W.; Saha, S.; Zhang, C. Curr. Top. Med. Chem. 2016, 16, 1727.
[3]
Liu, Y.; Wang, H.; Song, R.; Chen, J.; Li, T.; Li, Y.; Du, L.; Shen, Y. Org. Lett. 2018, 20, 3504.
[4]
Blodgett, J.; Oh, D.; Cao, S.; Currie, C.; Kolter, R.; Clardy, J. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 11692.
[5]
Yu, F.; Zaleta-Rivera, K.; Zhu, X.; Huffman, J.; Millet, J.; Harris, S.; Yuen, G.; Li, X.; Du, L. Antimicrob. Agents Chemother. 2007, 51, 64.
[6]
Li, Y.; Wang, H.; Liu, Y.; Jiao, Y.; Li, S.; Shen, Y.; Du, L. Angew. Chem., Int. Ed. 2018, 57, 6221.
[7]
Saha, S.; Zhang, W.; Zhang, G.; Zhu, Y.; Chen, Y.; Liu, W.; Yuan, C.; Zhang, Q.; Zhang, H.; Zhang, L.; Zhang, W.; Zhang, C. Chem. Sci. 2017, 8, 1607.
[8]
Zhang, G.; Zhang, W.; Zhang, Q.; Shi, T.; Ma, L.; Zhu, Y.; Li, S.; Zhang, H.; Zhao, Y.; Shi, R.; Zhang, C. Angew. Chem., Int. Ed. 2014, 53, 4840.
[9]
Qi, Y.; Ding, E.; Blodgett, J. ACS Synth. Biol. 2018, 7, 357.
[10]
Yu, H.; Jiang, S.; Bu, X.; Wang, J.; Weng, J.; Yang, X.; He, K.; Zhang, Z.; Ao, P.; Xu, J.; Xu, M. Sci. Rep. 2017, 7, 40689.
[11]
Li, Y.; Huffman, J.; Li, Y.; Du, L.; Shen, Y. MedChemComm 2012, 3, 982.
[12]
Greunke, C.; Antosch, J.; Gulder, T. Chem. Commun. 2015, 51, 5334.
[13]
Yan, Y.; Wang, H.; Song, Y.; Zhu, D.; Shen, Y.; Li, Y. ACS Synth. Biol. 2021, 10, 2434.
[14]
Jin, H.; Zhang, W.; Zhang, G.; Zhang, L.; Liu, W.; Zhang, C. Org. Lett. 2020, 22, 1731.
[15]
Zhang, W.; Zhang, G.; Zhang, L.; Liu, W.; Jiang, X.; Jin, H.; Liu, Z.; Zhang, H.; Zhou, A.; Zhang, C. Tetrahedron 2018, 74, 6839.
[16]
Jiao, Y.; Yan, Y.; Liu, Y.; Zhu, D.; Shen, Y.; Li, Y. Chin. J. Org. Chem. 2020, 40, 1779. (in Chinese)
[16]
(焦玉杰, 颜雅倩, 刘焱, 朱德裕, 沈月毛, 李瑶瑶, 有机化学, 2020, 40, 1779.)
[17]
Mosmann, T. J. Immunol. Methods 1983, 65, 55.
[18]
Li, J.; Lv, C.; Sun, W.; Li, Z.; Han, X.; Li, Y.; Shen, Y. Antimicrob. Agents Chemother. 2013, 57, 2191.
Outlines

/